The eccDNA sequencing and bioinformatics analysis revealed that eccDNA PAFAH1B3 (chr19:42803212-42803548) was significantly amplified in HCC and may be a potential biomarker in HCC patients. The gene discussed is PAFAH1B3; the disease is hepatocellular carcinoma.